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Abstract The rare occurrence of
angiosarcoma in postmastectomy
upper-limb lymphedema with mag-
netic resonance (MR) imaging is
discussed. Unfamiliarity with this
aggressive vascular tumor and its
harmless appearance often leads to
delayed diagnosis. Angiosarcoma
complicating chronic lymphedema
may be low in signal intensity on T2-
weighting and short tau inversion
recovery (STIR) imaging reflecting
the densely cellular, fibrous stroma,
and sparsely vascularized tumor his-
tology. Additional administration of
intravenous contrast medium re-
vealed significant enhancement of the
tumorous lesions. Awareness of an-
giosarcoma and its MR imaging ap-
pearance in patients with chronic
lymphedema may be a key to early
diagnosis or allow at least inclusion
in the differential diagnosis.
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Introduction
Lymphangiosarcoma of the upper limb was first described
in postmastectomy patients by Stewart and Treves in 1948
[1]. It is today a rare but still potentially highly lethal
vascular tumor occurring most often in chronic lymphe-
dema due to radical mastectomy. Other risk factors of
lymphedema that have been reported in association with
angiosarcoma include trauma, filarial infection, and id-
iopathic acquired lymphedema [2].
Unfamiliarity with this malignancy and the often in-
nocuous appearance may lead to delayed diagnosis. We
describe a case of upper-extremity angiosarcoma devel-
oping after mastectomy with emphasis on magnetic res-
onance (MR) imaging, which has rarely been reported in
the world radiology literature [3, 4]. The unusual features
of our case are the subcutaneous location and multiplicity
of the tumorous lesions as well as the decreased signal
intensity on T2-weighted images of a sarcoma that his-
tologically turned out to be an angiosarcoma.
Case report
An 80-year-old woman underwent a modified radical mastectomy
and axillary node dissection on the right side for a T4aN0M0 in-
vasive breast cancer. Postoperatively, the patient was irradiated
with a total dose of 58 Gy. Chronic lymphedema of the right upper
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limb developed shortly after radiation therapy (Fig. 1). Nine years
after mastectomy, the patient presented with a solid blue-reddish
nodular lesion on the dorsum of her right forearm measuring
approximately 36 cm. (Fig. 1). The tumorous lesion had grown
rapidly within 2 months. Physical examination revealed a second
satellite nodule of 0.8 cm in diameter on the volar aspect of the
forearm. Telangiectasias could be found on the massively swollen
right arm and on the lateral aspect of the breast and back. There was
no lymphadenopathy.
Histology of a punch biopsy from the center of the larger
forearm lesion demonstrated a vascular tumor consisting of a
mixture of spindle cells and vascular lumina deformed by pleo-
morphic endothelial cells (Fig. 2A,B). Immunohistochemistry was
positive for CD31 and factor VIII antigen, confirming the diagnosis
of angiosarcoma.
MR imaging was performed for local extent and compartment
anatomy for a presumed malignant soft tissue sarcoma. Prior to
scanning, a marker was placed adjacent to the smaller second le-
sions on the volar aspect of the forearm, since this is a part of our
protocol for tumor imaging, particularly for small lesions. The axial
MR images showed marked circumferential thickening of the
subcutaneous region consistent with the known lymphedema with
prominent skin thickening (Figs. 3A, 4A). There was no involve-
ment of the deep fascia or muscles. The two dermal nodules were of
decreased signal intensity on T1-weighted imaging compared with
surrounding fat and isointense to muscle ( Figs. 3A, 4A). Corre-
sponding T2-weighted fat-saturated images showed inhomoge-
neous predominantly decreased signal intensity compared to mus-
cle (Figs. 3B, 4B). The larger nodule extended into the subcuta-
neous fat layer by 3 mm, consistent with a more aggressive lesion
(Fig. 3A). The second smaller lesion was more evident on T2-
weighting and after intravenous contrast enhancement and re-
mained within the dermis. The obvious cutaneous discoloration and
tumorous mass together with the findings of the MR images al-
lowed easy identification of the larger tumor; however the smaller
lesion was less easy to recognize. After intravenous administration
of contrast medium (gadolinium dimeglumine), the two tumors
enhanced significantly (Figs. 3D, 4C). In the remaining subcuta-
neous tissue, there was no evidence of mass formation or irregu-
larity suggestive of additional tumors.
Fig. 1 Appearance of the larger lesion on the dorsum of the right
forearm with chronic lymphedema compared to the normal ap-
pearance of the left arm
Fig. 2 A Hematoxylin-and-eosin-stained histopathology, M10,
shows compact tumor nodule with very densely populated tumor
cells. Prominent fibrous stroma is evident (*). The skin surface is
demarcated (arrow). B Hematoxylin-and-eosin-stained histopa-
thology, M40, shows evidence of small, fine, sparse vessels (e.g.,
arrow) with diffuse stroma surrounding
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The patient insisted on limb salvage surgery and refused the
proposed amputation. The tumorous mass on the forearm and the
nodule on the volar aspect of the forearm were surgically removed
with a margin of 1 cm and vertically deep to the level of the fascia.
A mesh graft was transplanted with a very good functional result.
Seven months after the excision of the tumor the patient was still
free of recurrence or metastasis.
Discussion
Stewart-Treves syndrome (STS) was originally described
as lymphangio-sarcoma of the upper extremity occurring
many years after radical mastectomy for breast cancer
[1]. The clinical appearance of the tumor according to the
first descriptions of Stewart is “a slightly raised, macular
or polypoid lesion . . . a solitary tumor followed by similar
satellite areas that sometimes become confluent, forming a
larger lesion” [5]. The tumors often appear as bluish-black,
pink nodules on the edematous extremity, which tend to
ulcerate and bleed. The differential diagnosis of lymph-
angiosarcoma includes Kaposi sarcoma, skin metastasis,
malignant lymphoma, and deep infection of the skin.
Approximately 90% of the reported angiosarcomas
involve the upper limb after radical mastectomy with or
without radiotherapy [6]. Other rare causes for lymphan-
giosarcoma without prior breast carcinoma are trauma,
infection, or idiopathic acquired lymphedema [2]. Lymph-
edema due to cardiac, hepatic, renal, or metabolic dis-
ease is not associated with a higher risk of developing a
lymphangiosarcoma [6].
STS predominantly occurs in women. Only one case
of a male patient with STS due to a postmastectomy
lymphedema is reported [7]. The mean age of patients
with STS ranges between the fifth and seventh decade [8].
The age correlates with the highest incidence of breast
cancer.
In the 1960s, the incidence of STS varied from 0.07 to
0.45%. Today, due to changes in surgical technique, STS
Fig. 3 A Axial T1-weighted
image (TR: 600, TE: 14) shows
the large dermal lesion (white
arrows) with extension into
subcutaneous fat by 3 mm
(black arrowheads). Also noted
is the extensive circumferential
skin and soft tissue thickening,
consistent with the known
lymphedema. B Corresponding
axial FSE T2-weighted image
(TR: 5300, TE: 98) shows that
the tumor nodule (white arrows)
is largely of low signal intensi-
ty. The tumor nodules margins
were well-defined on T2
weighting (arrows). Adjacent
thickened skin is noted (arrow-
heads). Again the extensive
lymphedema is noted. The un-
derlying muscle has a normal
signal intensity. C Correspond-
ing axial short tau inversion
recovery (STIR) (T1:90, TR:
5680, TE: 15) shows the larger
tumor nodule remains decreased
in signal intensity. D Corre-
sponding axial postgadolinium
T1-weighted image (TR: 519,
TE: 14) shows diffuse contrast
enhancement within the tumor
(arrows). Adjacent thickened
skin contrast enhancement is
noted (arrowheads)
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of the upper extremity is a very rare event. Less radical
mastectomy, the avoidance of the combination of axillary
dissection and radiation, as well as the increased appli-
cation of sentinel node biopsy nowadays might lead to a
further reduction of the incidence of postmastectomy
angiosarcoma [9, 10].
The exact etiology of lymphangiosarcoma remains
unclear. The tumor arises from vascular endotheliocytes
and it is suggested that the malignancy is directly related
to chronic lymphedema and an alteration in immune
function [11]. The prevention of lymphedema might re-
duce the incidence of extremity angiosarcoma, and this
is strongly recommended by many authors [6, 12]. The
mean latency period between the onset of the lymphe-
dema and the appearance of the angiosarcoma is about
10–11 years [13].
Because of the rare occurrence of STS, there is little
evidence on how lymphangiosarcoma should be optimally
treated. Many authors believe that early surgical removal
offers the best chance for prolonged survival; however, it
is almost always followed by disease recurrence [2, 12,
14]. Other treatment strategies like external radiothera-
py and chemotherapy (e.g., 5-fluorouracil, methotrexate,
vincristine, bleomycin and vinblastine) are equally unsat-
isfactory. Both therapy options do not improve the overall
long-term survival in patients with STS [12, 13, 14]. Iso-
lated limb perfusion with TNFa and melphalan proved to
be efficient in a series of ten patients with multifocal le-
sions with 56% complete remission in a mean follow-up of
35 months [15]. However, it has to be emphasized that the
survival of patients with STS is very poor, ranging from 19
to 31 months [14]. Most patients die of metastatic disease
to the lungs [14]. Even if we lack evidence that the early
recognition of lymphangiosarcoma is the key to a longer
survival, a close follow-up of all patients with postmas-
tectomy lymphedema is recommended.
MR is an established imaging modality in the inves-
tigation of accurate anatomical definition of peripheral
lymphedema [16, 17]. Currently, there have been only
two reports published on the MR appearance of angio-
sarcoma associated with chronic lymphedema of the
lower extremity [3, 4]. In our case, we present the MR-
based morphological features of a patient with a post-
mastectomy upper limb angiosarcoma. The MR images
revealed a diffuse dermal and subcutaneous circumfer-
ential edema involving the entire forearm, characteristic
for a peripheral lymphedema. The two dermal nodules
involving the subcutaneous region were isointense to
muscle on T1-weighted and largely decreased signal in-
tensity on T2-weighted images.
Nakazono et al. in 2000 described two cases of sub-
cutaneous angiosarcomas of the lower limb associated
with chronic lymphedema with MR imaging after hys-
terectomy [4]. Both tumors were isointense with muscle
on T1 weighting and were largely decreased in signal
intensity on T2 weighting. Interestingly, the nodules in
Fig. 4 A Axial T1-weighted image (TR: 600, TE: 14) with marker
adjacent to the clinical reddish tumor nodule shows focal skin
thickening and absence of subcutaneous involvement. B Corre-
sponding axial FSE T2-weighted image (TR: 5300, TE: 90) shows
the well-defined margins of the intradermal tumor (arrows), which
measured 8 mm in length and was decreased in signal intensity. The
extensive lymphedema of the subcutaneous region is noted as well
as normal musculature. C Corresponding axial postgadolinium T1-
weighted image (TR: 519, TE: 14) shows significant enhancement
of the nodule
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our patient also had a decreased signal intensity on T2 and
short tau inversion recovery (STIR) imaging (Fig. 3C).
For a highly vascular malignant tumor, the decreased
signal intensity on T2 weighting and STIR images is most
unusual. Geographic areas of low signal intensity (short
T2) have been described with fibrosarcoma, malignant
fibrous histiocytoma, aggressive fibromatosis, and giant
cell tumor of the tendon sheath [18]. The differential di-
agnosis of multiple soft tissue masses includes aggressive
fibromatosis, desmoid tumors, neurofibromatosis, and
Kaposi sarcoma [19]. However, these masses are easily
distinguishable from our current case from the clinical
and imaging appearance.
The second smaller lesion was evident with decreased
signal on T2 weighting and was more prominently re-
vealed after the administration of gadolinium. Therefore,
the use of contrast medium in the setting of chronic
lymphedema is recommended, even if it is of limited
value for conspicuity and staging in musculoskeletal
neoplasms [20].
After review of the MR images and the histological
examination with the pathologist, we presume the low
signal intensity was due to the relative sparsity of small
vessels and the relative prominence of fibrous stroma with
compact tumor cells. This agrees with the statement by
Nakazono, who believes that the signal intensity on T2-
weighted images expresses the ratio between the vascular
spaces and the tumor cells [4]. Gelmetti et al. reported a
case of lymphangiosarcoma of the lower limb with high
signal intensity on T2-weighted images [3]. However,
there was no histological correlation.
In our case and in the two other cases from the liter-
ature, the postintravenous, contrast-enhanced, fat-satu-
rated MR images demonstrated a marked contrast en-
hancement within the tumor nodule with well-delineated
margins.
In conclusion, awareness of angiosarcoma and its ap-
pearance in patients with chronic lymphedema may allow
for improved and accurate MR imaging preoperative di-
agnosis.
